Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once versus twice daily mesalazine to induce remission in pediatric ulcerative colitis
2012-004851-35Phase 4Completed
- Sponsor
- New Children's Hospital
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Salcrozine in autoimmune colitis (2 arms), sponsored by New Children's Hospital. Started Dec 2012; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2012-004851-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004851-35.